Skip to content

Price / sales at other companies

PTC Therapeutics logo
PTC TherapeuticsPTCT
6.8×+4.6×
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
3.5×+0.7×
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
1.3×+0.4×
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
27.3×+2.9×
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
9.8×+4.0×
LQD
Liquidia CorporationLQDA
11.5×-77.4×

Other financials

Income statement

See full
Revenue$149.4M+5.6%
Gross profit$134.9M+9.2%
Operating income$73.2M+15.6%
Net income$63.7M+12.3%
EPS (diluted)$0.50+11.1%

Balance sheet

See full
Cash & equivalents$755.9M+30.2%
Total debt$2.7M-13.3%
Total equity$1.0B+27.5%
Total assets$1.1B+26.3%

Cash flow

See full
Operating cash flow$59.6M-0.8%
CapEx$27.0K
Free cash flow$59.6M-0.8%

Valuation

See full
Market cap$3.84B+2.7%
Enterprise value$3.09B-4.1%
P/E17.4×-1.6×

Profitability

See full
Gross margin86%-0.2pp
Operating margin44.8%+1.6pp
Net margin37.1%+0.2pp
FCF margin34.9%-15.2pp

Returns & leverage

See full
Return on equity24.5%-4.6pp
Debt / equity0.0×
Current ratio7.1×+1.0×

Where this comes from

Calculated from Catalyst Pharmaceutical’s reported figures.

Based on the most recent quarter.

The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Catalyst Pharmaceutical's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Catalyst Pharmaceutical's price / sales?
Catalyst Pharmaceutical (CPRX) reported price / sales of 5.1× in Q1 2026.
How has Catalyst Pharmaceutical's price / sales changed year-over-year?
Catalyst Pharmaceutical's price / sales decreased by 8.0% year-over-year, from 5.5× to 5.1×.
What is the long-term trend for Catalyst Pharmaceutical's price / sales?
Over 5 years (2020 to 2025), Catalyst Pharmaceutical's price / sales has grown at a 11.0% compound annual growth rate (CAGR), from 2.9× to 4.9×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.